BioRestorative Therapies, Inc. (BRTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Cash from Operations | -3.81M | -2.42M | -2.9M | -2.69M | -2.78M | -2.35M | -1.7M | -1.87M | -2.32M | -1.77M | -1.18M | -1.28M | -2.38M | -1.57M | -1.45M | -1.25M | -1.59M | -1.15M | -629.36K | -741.83K |
| Operating CF Margin % | -16434.15% | -12322.31% | -24585.91% | -888.19% | -11115.14% | -5422.27% | -727.55% | -2093.34% | -6622.23% | -9188.74% | -3841.75% | -1990.01% | -7601.52% | -42522.95% | -5005.71% | -1759.67% | -9966.46% | -22900.28% | -7867.05% | -4945.52% |
| Operating CF Growth % | -37.03% | -2.87% | -70.7% | -44.43% | -19.89% | -32.39% | -44.1% | -45.31% | 2.58% | -12.72% | 18.75% | -2.59% | -49.21% | -37.41% | -130.65% | -68.65% | -95.97% | -100.14% | -20.32% | -76.44% |
| Net Income | -2.15M | -3.21M | -3.04M | -2.66M | -5.34M | -1.64M | -1.09M | -4.03M | -2.22M | 1.17M | 4.77M | -5.71M | -7.17M | -4.35M | -4.66M | -4.68M | -4.82M | -20.4M | -4.18M | -4.06M |
| Depreciation & Amortization | 52.39K | 52.84K | 52.62K | 52.75K | 51.78K | 50.37K | 48.27K | 47.7K | 42.71K | 42.71K | 42.15K | 41.53K | 39.35K | 31.79K | 31.23K | 31.52K | 26.01K | 50.56K | 21.58K | 75.02K |
| Stock-Based Compensation | 290.21K | 447.86K | 399.93K | 468.71K | 2.01M | 175.63K | 284.25K | 324.32K | 2.03M | 0 | 1.45M | 1.49M | 3.38M | 3.06M | 3.07M | 3.1M | 3.38M | 0 | 2.93M | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | -1.23M | -603.66K | -671.4K | -648.33K | 531.32K | -1.03M | -1.16M | 1.6M | -1.69M | -3.12M | -7.63M | 2.62M | 1.45M | 19.53K | 48.91K | 29.01K | -220.99K | 19.42M | 375.98K | 3.25M |
| Working Capital Changes | -769.81K | 895.43K | 355.99K | 89.27K | -31.21K | 88.59K | 222.77K | 192.99K | -475.7K | 129.06K | 181.23K | 283.01K | -77.97K | -335.4K | 49.51K | 259.44K | 40.59K | -216.74K | 230.85K | -6.09K |
| Change in Receivables | 2.2K | -2.1K | 1.6K | 10K | 163.4K | -23.4K | -137.6K | 7.6K | -15.7K | 20K | -14.3K | -9K | 0 | 29K | -29K | 0 | -11K | 3K | 7K | 3K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -682K | 482.45K | 230.21K | 10.43K | 116.43K | 81.69K | 185.46K | -14.98K | 41.51K | -37.97K | -48.69K | 183.46K | -78.32K | -297.6K | 90.27K | 164.34K | 163.07K | -73.73K | 26.87K | -147.97K |
| Cash from Investing | 968.45K | 2.4M | 2M | 2.13M | 2.37M | 1.53M | 936.75K | 2.97M | -4.93M | 100.67K | -21.36K | 819.03K | 2.54M | -3.32M | -9.91M | -137.67K | -109.57K | -30.66K | 0 | 0 |
| Capital Expenditures | 0 | -79.67K | 0 | 0 | -36.4K | -12.43K | -58.46K | -35.3K | 0 | -70.02K | -11.95K | -29.05K | -60.02K | -42.58K | 24.61K | -137.67K | -109.57K | -30.66K | 0 | 0 |
| CapEx % of Revenue | - | 406.47% | 0.03% | - | 145.6% | 28.72% | 25.03% | 39.61% | - | 362.82% | 38.92% | 45.04% | 191.76% | 1150.84% | 84.84% | 193.63% | 684.83% | 613.16% | - | 0.01% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -175K | -9.93M | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 4.44M | 923.24K | -49.31K | 888.14K | 1.09M | -126.32K | 0 | -12.84K | 7.52M | 83.07K | 1.85M | 411.7K | 0 | 0 | 0 | 0 | 0 | 21.07M | 0 | 0 |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 4.44M | 1.08M | 0 | 927.34K | 1.08M | 0 | 0 | 0 | 0 | 83.07K | 1.85M | 411.7K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | -6.06K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 6.06K | -160.51K | -49.31K | -39.2K | 8.8K | -126.32K | 0 | -12.84K | 7.52M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 21.07M | 0 | 0 |
| Net Change in Cash | 1.6M | 908.74K | -952.81K | 326.46K | 680.9K | -941.55K | -762.8K | 1.1M | 272.7K | -1.55M | 653.22K | -52.82K | 159.89K | -4.9M | -11.36M | -1.39M | -1.7M | 19.9M | -629.36K | -741.83K |
| Free Cash Flow | -3.81M | -2.49M | -2.9M | -2.69M | -2.82M | -2.36M | -1.76M | -1.9M | -2.32M | -1.84M | -1.19M | -1.31M | -2.44M | -1.79M | -1.43M | -1.39M | -1.7M | -1.18M | -629.36K | -741.83K |
| FCF Margin % | -16434.15% | -12728.79% | -24585.93% | -888.19% | -11260.74% | -5450.99% | -752.57% | -2132.95% | -6622.23% | -9551.55% | -3880.67% | -2035.04% | -7793.29% | -48403.51% | -4920.87% | -1953.3% | -10651.29% | -23513.4% | -7867.05% | -4945.53% |
| FCF Growth % | -35.26% | -5.7% | -65.02% | -41.75% | -21.46% | -28.04% | -47.56% | -44.79% | 4.98% | -2.93% | 16.52% | 5.49% | -43.13% | -52.33% | -126.74% | -87.21% | -109.44% | -105.49% | -20.32% | -76.44% |
| FCF per Share | -0.42 | -0.28 | -0.32 | -0.31 | -0.34 | -0.30 | -0.22 | -0.23 | -0.35 | -0.39 | -0.26 | -0.34 | -0.66 | -0.49 | -0.39 | -0.38 | -0.48 | -1.35 | -0.72 | -0.89 |
| FCF Conversion (FCF/Net Income) | 1.77x | 0.75x | 0.95x | 1.01x | 0.52x | 1.43x | 1.56x | 0.46x | 1.04x | -1.51x | -0.25x | 0.22x | 0.33x | 0.36x | 0.31x | 0.27x | 0.33x | 0.06x | 0.15x | 0.18x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |